Stress hormones predict cerebrovascular re-events after transient ischemic attacks

Neurology

Volumn 76, Issue 6, 2011, Pages 563-566

  Katan, M ^a   Nigro, N ^a   Fluri, F ^a   Schuetz, P ^a   Morgenthaler, N G ^b   Jax, F ^a   Meckel, S ^a   Gass, A ^a   Bingisser, R ^a   Steck, A ^a   Kappos, L ^a   Engelter, S ^a   Muller B ^c   Christ Crain, M ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b BRAHMS AG   (Germany)

^c CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COPEPTIN; HYDROCORTISONE; STRESS HORMONE; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EMERGENCY WARD; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; SCORING SYSTEM; TRANSIENT ISCHEMIC ATTACK;

EID: 79951641838     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31820b75e6     Document Type: Article

References (11)

1. Hill MD, Yiannakoulias N, Jeerakathil T, Tu JV, Svenson LW, Schopflocher DP. The high risk of stroke immediately after transient ischemic attack: a population-based study. Neurology 2004;62:2015-2020. (Pubitemid 38738214)
2. Cucchiara BL, Messe SR, Taylor RA, et al. Is the ABCD score useful for risk stratification of patients with acute transient ischemic attack? Stroke 2006;37:1710-1714. (Pubitemid 44297717)
3. Fassbender K, Schmidt R, Mossner R, Daffertshofer M, Hennerici M. Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke: relation to acute con-fusional state, extent of brain damage, and clinical outcome. Stroke 1994;25:1105-1108. (Pubitemid 24164746)
4. Struck J, Morgenthaler NG, Bergmann A. Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides 2005;26: 2500-2504. (Pubitemid 41676723)
5. Katan M, Fluri F, Morgenthaler NG, et al. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol 2009;66:799-808.
6. Dennis MS, Bamford JM, Sandercock PA, Warlow CP. A comparison of risk factors and prognosis for transient ischemic attacks and minor ischemic strokes: The Oxfordshire Community Stroke Project. Stroke 1989;20: 1494-1499. (Pubitemid 19278135)
7. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007; 369:283-292. (Pubitemid 46136488)
8. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41. (Pubitemid 23014379)
9. Katan M, Morgenthaler N, Widmer I, et al. Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro Endocrinol Lett 2008;29:341-346.
10. Darzy KH, Dixit KC, Shalet SM, Morgenthaler NG, Brabant G. Circadian secretion pattern of copeptin, the C-terminal vasopressin precursor fragment. Clin Chem Epub 2010 Apr 22.
11. Lavallee PC, Meseguer E, Abboud H, et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol 2007;6:953-960. (Pubitemid 47570023)